Jeffrey Robert Ajer, Director at NEKTAR THERAPEUTICS (NKTR), sold 7,330 shares at $17.78 ($130K) on 2021-09-22, disclosed to the SEC on 2021-09-24.
Seasonal sale ($130k) by Director — this insider has traded NKTR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.78 | 3,665 | $65K | 50.0% |
| 2 | $17.78 | 3,665 | $65K | 50.0% |
| Total | $17.78 avg | 7,330 | $130K | 100% |
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |